SAM
MDGL icon

Smartleaf Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Smartleaf Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.8K Sell
150
-37
-20% -$17.7K ﹤0.01% 1249
2025
Q4 		$109K Buy
187
+63
+51% +$32.2K ﹤0.01% 1143
2025
Q3 		$54.9K Buy
124
+73
+143% +$27.2K ﹤0.01% 1353
2025
Q2 		$15.3K Sell
51
-35
-41% -$10.4K ﹤0.01% 1665
2025
Q1 		$28.2K Buy
86
+1
+1% +$329 ﹤0.01% 1431
2024
Q4 		$26.5K Buy
85
+16
+23% +$4.5K ﹤0.01% 1491
2024
Q3 		$14.7K Buy
69
+42
+156% +$10.7K ﹤0.01% 1527
2024
Q2 		$7.71K Buy
+27
New +$6.43K ﹤0.01% 1553

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return